Neurology Minute
1,957 episodes — Page 37 of 40
Pharmacologic treatment for pediatric migraine prevention
Dr. Andrew Hershey provides the main takeaways of his paper on pharmacologic treatment for pediatric migraine prevention
Remote electrical neuromodulation
Dr. Teshamae Monteith discusses remote electrical neuromodulation.
CIDP
Dr. Ted Burns talks about CIDP basics and diagnosis.
Continuum pearls: higher cortical visual disorders, pt. 1
Dr. Sashank Prasad and Dr. Marc Dinkin discuss higher cortical visual disorders in the first part of a three-part series. To learn more, read the article "Higher Cortical Visual Disorders" by Drs. Prasad and Dinkin in the October 2019 Neuro-ophthalmology issue of Continuum.
More prominent muscle involvement in dermatomyositis patients with anti-Mi2 autoantibodies
Dr. Andrew Mammen talks about what clinicians need to know about this subtype of dematomyositis.
Looking back on life of Oliver Sacks with Lawrence Weschler, pt. 2
In a highlight from the second part of a two-part interview with Lawrence Weschler, Oliver Sacks biographer, he discusses Sacks' legacy.
Distal parasthesias
Dr. Fabio Nascimento discuss distal parasthesias, from a Teaching Video NeuroImages article in Neurology.
Continuum Pearls: diplopias, pt. 3
Dr. Christopher Glisson discusses diplopia in the third part of a three-part series. To learn more, read the article "Approach to Diplopia" by Dr. Glisson in the October 2019 Neuro-ophthalmology issue of Continuum.
Autologous, nonmyeloablative hematopoietic stem-cell transplantation for neuromyelitis optica
Dr. Richard Burt discusses the main takeaways from his paper on autologous, nonmyeloablative hematopoietic stem-cell transplantation for neuromyelitis optica.
Looking Back on the Life of Oliver Sacks, pt. 1
Here's a highlight from the 1st part of our 2-part interview on the life of Oliver Sacks with Lawrence Weschler.
Progressive solitary sclerosis
Dr. Eoin Flanagan discusses progressive solitary sclerosis.
Cancer risk in Parkinson disease
Dr. Jeff Ratliff highlights a Neurology Today article in discussing cancer risk in Parkinson disease. Read the article here: https://journals.lww.com/neurotodayonline/Fulltext/2019/09190/In_Small_Study,_Parkinson_s_Disease_Patients_with.1.aspx.
Continuum Pearls: diplopias, pt. 2
Dr. Christopher Glisson discusses diplopia in the second part of a three-part series. To learn more, read the article "Approach to Diplopia" by Dr. Glisson in the October 2019 Neuro-ophthalmology issue of Continuum.
High precision plasma amyloid-β 42/40 predicts current and future brain amyloidosis
Dr. Randall Bateman gives the main takeaways from his paper addressing how high precision plasma amyloid-β 42/40 predicts current and future brain amyloidosis.
Nobel Prize winner Stanley Prusiner, pt. 2
In this highlight from our longer interview with Dr. Stanley Prusiner, Dr. Prusiner talks about what he would do differently if he could go back and do it all over.
CAA-related inflammation
Dr. Aaron Rothstein discusses cerebral amyloid angiopathy.
Continuum Pearls: Diplopia, pt. 1
Dr. Christopher Glisson discusses diplopia in the first part of a three-part series. To learn more, read the article "Approach to Diplopia" by Dr. Glisson in the October 2019 Neuro-ophthalmology issue of Continuum.
Orthostatic hypotension in Parkinson disease
Dr. Ylva Hiorth provides the main clinical messages from her study on orthostatic hypertension in Parkinson disease.
Nobel Prize winner Dr. Stanley Prusiner
Listen to an excerpt from the interview with Nobel Prize winner Dr. Stanley Prusiner.
Hippocampal sclerosis in cerebral malaria
Dr. Aaron Rothstein discusses a paper in the Resident & Fellow section on hippocampal sclerosis in cerebral malaria.
Anti-Ma2 paraneoplastic syndrome
Dr. Eoin Flanagan discusses anti-Ma2 paraneoplastic syndrome.
The World Health Organization's essential diagnostics list: Diagnostics for neurologic disorders
Dr. Kiran Thakur and Dr. Greer Waldrop give the main takeaways from their paper on the World Health Organization's essential diagnostics list.
Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
Dr. Sean Pittock discusses the main takeaways from his article on eculizumab in aquaporin-4–positive neuromyelitis optica spectrum disorder.
Inflammatory subtype of cerebral amyloid angiopathy
Dr. Aaron Rothstein discusses a less well-known imaging finding on a inflammatory subtype of cerebral amyloid angiopathy.
McArdle sign in MS
Dr. Eoin Flanagan discusses the McArdle sign in multiple sclerosis.
Combination therapy with nusinersen and AVXS-101 in SMA type 1
Dr. Emma Ciafaloni discusses the main takeaways from her paper combination therapy with nusinersen and AVXS-101 in SMA type 1.
Neuroimaging Findings in US Government Personnel With Possible Exposure to Directional Phenomena in Havana, Cuba
Dr. Douglas Smith discusses the main takeaways from his paper, "Neuroimaging Findings in US Government Personnel With Possible Exposure to Directional Phenomena in Havana, Cuba" from JAMA.
World travel reporting of neurologic care: Thailand
In the first part of a multi-part series, Dan Xia talks about what he learns about neurologic care from his travels around the world, this time from Thailand.
Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis
Dr. Mauricio Farez talks about the main points from his practice guidelines paper on vaccine-preventable infections and immunization in multiple sclerosis.
Drug Pricing Update Part 1
Dr. Steve Pearson gives more takeaways from the second part of his update discussion with Dr. Gordon Smith on drug pricing.
Interpretation of antibody titers in paraneoplastic and autoimmune neuroantibody testing
Dr. Rae Bacharach discusses interpretation of antibody titers in paraneoplastic and autoimmune neuroantibody testing.
Upward gaze palsy
Dr. Fabio Nascimento discusses upward gaze palsy
Gender Equity in Neurology
Dr. Julie Silver discusses the main takeaways from her paper on understanding and addressing gender equity for women in neurology.
Drug Pricing Update Part 1
Dr. Steve Pearson give the main takeaways from his update discussion with Dr. Gordon Smith on drug pricing.
Oculopalatal myoclonus
Dr. Fabio Nascimento discusses clinical pearls on oculopalatal myoclonus.
Next Gen Sequencing Diagnosis of Encephalitis, pt. 2
Dr. Mike R. Wilson continues with more takeaways from his talk on next gen sequencing diagnosis of encephalitis.
Checkpoint Inhibitior Associated Neuropathy
Dr. Amanda Guidon and Dr. Divyanshu Dubey discuss the main takeaways from the discussion on checkpoint inhibitor associated neuropathy.
Next Gen Sequencing Diagnosis of Encephalitis
Dr. Mike R. Wilson the takeaways from his discussion on clinical metagenomic sequencing for diagnosis of meningitis and encephalitis.
AAN Fall Conference 2019
Dr. Jonathan Graff-Radford discusses highlights of the upcoming AAN Fall Conference in Las Vegas.
Acute nerve agent poisoning
Dr. Jonathan Newmark discusses the main takeaways on acute nerve agent poisoning.
Detection of brain activation in unresponsive patients with acute brain injury
Dr. Jan Claassen discusses the main takeaways from his NEJM paper on detection of brain activation in unresponsive patients with acute brain injury.
CMS proposal of new payment rule
Dr. Jason Crowell discusses important changes to the CMS' new proposed payment rule.
Continuum Pearls: Tremor, pt. 3
Dr. Elan Louis discusses tremor in the third part of a three-part series. To learn more, read the article "Tremor" by Dr. Louis in the August 2019 Movement Disorders issue of Continuum.
Continuum Pearls: Tremor, pt. 2
Dr. Elan Louis discusses tremor in the second part of a three-part series. To learn more, read the article "Tremor" by Dr. Louis in the August 2019 Movement Disorders issue of Continuum.
Zika update 2019
Dr. Amanda Grenell discusses the main takeaways from her Zika virus update.
Tackling the imposter phenomenon and addressing disparities for women in neurologic practice
Dr. Jason Crowell highlights a commentary in Neurology: Clinical Practice on the imposter phenomenon and advancing women in neurology practice. You can read the commentary here: https://cp.neurology.org/content/9/2/155.
New FDA approval of sIRNA therapies
Dr. Jeff Ratliff discusses FDA approval of new sIRNA therapies.
Continuum Pearls: Tremor
Dr. Elan Louis discusses tremor in the first part of a three-part series. To learn more, read the article "Tremor" by Dr. Louis in the August 2019 Movement Disorders issue of Continuum.
A new paraneoplastic biomarker
Dr. Anastasia Zekeridou discusses the main takeaways from her paper on a new paraneoplastic biomarker.
"Evergreen" Drug Prices
Prof. Robin Feldman discusses "evergreen" drug pricing, from her paper in the Journal of Law and the Biosciences, which you can read here: https://academic.oup.com/jlb/article/5/3/590/5232981.